These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30661225)

  • 1. Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk.
    Laczmanska I; Sasiadek MM
    J Appl Genet; 2019 Feb; 60(1):57-62. PubMed ID: 30661225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments on: "Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk".
    Gholami M; M Amoli M
    J Appl Genet; 2019 Nov; 60(3-4):431-433. PubMed ID: 31301025
    [No Abstract]   [Full Text] [Related]  

  • 3. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.
    Mita Y; Yasuda Y; Sakai A; Yamamoto H; Toyooka S; Gunduz M; Tanabe S; Naomoto Y; Ouchida M; Shimizu K
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):249-59. PubMed ID: 19672627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
    Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
    Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PTPRJ genotype in papillary thyroid carcinoma risk.
    Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A
    Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
    Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
    Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer.
    Zhang XF; Tu R; Li K; Ye P; Cui X
    J Cell Biochem; 2017 Oct; 118(10):3391-3400. PubMed ID: 28316102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Colorectal cancer susceptibility genetic variants in tumor free and colorectal carcinoma bearing Hungarian population. Individual predisposition to cancer].
    Szentirmay Z; Kurcsics J; Csernák E; Tándor I; Tóth E
    Orv Hetil; 2018 Oct; 159(40):1614-1623. PubMed ID: 30277414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No impact of PTPN22, PTPRJ and ACP1 genes polymorphisms on the risk of immune thrombocytopenia in French adult patients.
    Lioger B; Rollin J; Vayne C; Perret-Gallix K; Pouplard C; Godeau B; Michel M; Gruel Y
    Thromb Res; 2016 Aug; 144():76-8. PubMed ID: 27309885
    [No Abstract]   [Full Text] [Related]  

  • 13. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
    Ruivenkamp C; Hermsen M; Postma C; Klous A; Baak J; Meijer G; Demant P
    Oncogene; 2003 May; 22(22):3472-4. PubMed ID: 12776199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPRJ is downregulated in cervical squamous cell carcinoma.
    Roychowdhury A; Basu M; Pal D; Dutta P; Samadder S; Mondal R; Roy AK; Roychoudhury S; Panda CK
    J Genet; 2022; 101():. PubMed ID: 35791609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer.
    Venkatachalam R; Ligtenberg MJ; Hoogerbrugge N; Schackert HK; Görgens H; Hahn MM; Kamping EJ; Vreede L; Hoenselaar E; van der Looij E; Goossens M; Churchman M; Carvajal-Carmona L; Tomlinson IP; de Bruijn DR; Van Kessel AG; Kuiper RP
    Gastroenterology; 2010 Dec; 139(6):2221-4. PubMed ID: 21036128
    [No Abstract]   [Full Text] [Related]  

  • 16. Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review.
    Belhadj S; Terradas M; Munoz-Torres PM; Aiza G; Navarro M; Capellá G; Valle L
    Hum Mutat; 2020 Sep; 41(9):1563-1576. PubMed ID: 32449991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
    Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
    Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.
    Casagrande S; Ruf M; Rechsteiner M; Morra L; Brun-Schmid S; von Teichman A; Krek W; Schraml P; Moch H
    J Pathol; 2013 Mar; 229(4):525-34. PubMed ID: 23007793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.
    Trapasso F; Drusco A; Costinean S; Alder H; Aqeilan RI; Iuliano R; Gaudio E; Raso C; Zanesi N; Croce CM; Fusco A
    DNA Cell Biol; 2006 Jun; 25(6):376-82. PubMed ID: 16792508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
    Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
    Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.